Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Combining iron supplements with Qilib lotion is more effective for treating hair loss from iron deficiency.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Dupilumab can both heal and cause hair loss.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Tofacitinib helped regrow hair in most patients with severe hair loss.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Dupilumab may help regrow hair in people with severe alopecia.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.